Journal
CELL REPORTS
Volume 3, Issue 3, Pages 881-891Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2013.02.014
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft [SFB832]
- Deutsche Krebshilfe [SFB670, SFB635]
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases
- Research Unit FOR885
- DIP grant [HO 2541/4-1]
Ask authors/readers for more resources
The BH3-only protein NOXA represents one of the critical mediators of DNA-damage-induced cell death. In particular, its involvement in cellular responses to cancer chemotherapy is increasingly evident. Here, we identify a strategy of cancer cells to escape genotoxic chemotherapy by increasing proteasomal degradation of NOXA. We show that the deubiquitylating enzyme UCH-L1 is a key regulator of NOXA turnover, which protects NOXA from proteasomal degradation by removing Lys(48)-linked polyubiquitin chains. In the majority of tumors from patients with melanoma or colorectal cancer suffering from high rates of chemoresistance, NOXA fails to accumulate because UCH-L1 expression is epigenetically silenced. Whereas UCH-L1/NOXA-positive tumor samples exhibit increased sensitivity to genotoxic chemotherapy, downregulation of UCH-L1 or inhibition of its deubiquitylase activity resulted in reduced NOXA stability and resistance to genotoxic chemotherapy in both human and C. elegans cells. Our data identify the UCH-L1/NOXA interaction as a therapeutic target for overcoming cancer chemoresistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available